Tixupharma
Regenerative Therapeutics
Discovery platform to develop metabolic therapeutics to treat chronic and/or aging diseases.
About Us
Tixupharma is an innovative medical device company based in Milan, established in 2013 as academic spin-out and consolidated in 2019 to pioneer untapped regenerative pathways in age-related and traumatic diseases.
Form 2026 onward activities will re-split into two entities: Tixupharma Srl to continue the development of substance-based medical device under a new management; whilst Tixupharma of Carlo Ghisalberti will focus on aesthetic medicine and advanced cosmeceutical solutions.
Mission
Worldwide, millions of people suffer from unmet degenerative diseases requiring effective therapeutics.
Tixupharma Srl's mission is to develop first-in-class therapies to treat such diseases by leveraging mechanotransduction driving-forces starting from unmet women's healthcare needs.
Other emerging aesthetic issues of the aging population will be managed by a separate entity, who just continues a tradition of tissue regeneration in a non-therapeutic regulatory frame.
Regenerative Approach
The initiatives exploit non-pharmacologic, autocrine signaling pathways to advance either therapeutics (medical device) for unmet or undeserved medical needs; or the opportunities in aesthetic medicine and female wellbeing.


